Psychometric evidence of a perception scale about covid-19 vaccination process in Peruvian dentists: a preliminary validation

Cayo-Rojas, César F.; Córdova-Limaylla, Nancy; Briceño-Vergel, Gissela; Ladera-Castañeda, Marysela; Cachay-Criado, Hernán; López-Gurreonero, Carlos; Cornejo-Pinto, Alberto; Cervantes-Ganoza, Luis

doi:10.1186/s12913-022-08677-w

Table 2 Aiken’s V for the evaluation of the clarity, objectivity, timeliness, organization, sufficiency, intentionality, consistency, coherence and methodology of the P-Vac-Cov19-DENT scale items

From: Psychometric evidence of a perception scale about covid-19 vaccination process in Peruvian dentists: a preliminary validation

Item	Clarity		Objectivity		Timeliness		Organization		Sufficiency		Intentionality		Consistency		Coherence		Methodology
Item	V	95% CI	V	95% CI	V	95% CI	V	95% CI	V	95% CI	V	95% CI	V	95% CI	V	95% CI	V	95% CI
Q1	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.95	0.76–0.99
Q2	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.95	0.76–0.99
Q3	1.00	0.84–1.00	0.95	0.76–0.99	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97	1.00	0.84–1.00	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99
Q4	0.95	0.76–0.99	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97
Q5	0.95	0.76–0.99	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.95	0.76–0.99
Q6	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97
Q7	0.90	0.70–0.97	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99
Q8	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	1.00	0.84–1.00	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99
Q9	1.00	0.84–1.00	1.00	0.84–1.00	1.00	0.84–1.00	0.95	0.76–0.99	0.95	0.76–0.99	1.00	0.84–1.00	1.00	0.84–1.00	1.00	0.84–1.00	0.90	0.70–0.97
Q10	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97	1.00	0.84–1.00	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97
Q11	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97
Q12	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97
Q13	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	1.00	0.84–1.00	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	1.00	0.84–1.00
Q14	0.90	0.70–0.97	0.90	0.70–0.97	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97
Q15	1.00	0.84–1.00	1.00	0.84–1.00	0.95	0.76–0.99	0.95	0.76–0.99	0.95	0.76–0.99	1.00	0.84–1.00	1.00	0.84–1.00	0.90	0.70–0.97	0.95	0.76–0.99
Q16	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97
Q17	1.00	0.84–1.00	0.90	0.70–0.97	0.90	0.70–0.97	1.00	0.84–1.00	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97
Q18	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97	0.95	0.76–0.99	0.95	0.76–0.99	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97	0.90	0.70–0.97

Aiken’s V coefficient, 95% CI

Back to article page

ISSN: 1472-6963

Contact us

General enquiries: journalsubmissions@springernature.com

BMC Health Services Research

Contact us